Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia

Background: We aimed to analyze the impact of cefotaxime non-susceptibility on the 30-day mortality rate in patients receiving a third-generation cephalosporin for pneumococcal bacteremic pneumonia. Methods: We conducted a retrospective observational study of prospectively collected data from the Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Cillóniz, Catia, de la Calle, Cristina, Dominedò, Cristina, García-Vidal, Carolina, Cardozo, Celia, Gabarrús, Albert, Marco, Francesc, Torres, Antoni, Soriano, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722634/
https://www.ncbi.nlm.nih.gov/pubmed/31374996
http://dx.doi.org/10.3390/jcm8081150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722634/
https://www.ncbi.nlm.nih.gov/pubmed/31374996
http://dx.doi.org/10.3390/jcm8081150

Ejemplares similares